- Home
- ASB vs ACAD Comparison
ASB vs ACAD Comparison
Compare ASB & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASB
- ACAD
- Stock Information
- Founded
- ASB 1861
- ACAD 1993
- Country
- ASB United States
- ACAD United States
- Employees
- ASB N/A
- ACAD N/A
- Industry
- ASB Major Banks
- ACAD Biotechnology: Pharmaceutical Preparations
- Sector
- ASB Finance
- ACAD Health Care
- Exchange
- ASB Nasdaq
- ACAD Nasdaq
- Market Cap
- ASB 3.6B
- ACAD 2.9B
- IPO Year
- ASB N/A
- ACAD 2004
- Fundamental
- Price
- ASB $25.17
- ACAD $17.39
- Analyst Decision
- ASB Hold
- ACAD Buy
- Analyst Count
- ASB 9
- ACAD 19
- Target Price
- ASB $26.00
- ACAD $26.44
- AVG Volume (30 Days)
- ASB 1.8M
- ACAD 1.5M
- Earning Date
- ASB 01-23-2025
- ACAD 11-06-2024
- Dividend Yield
- ASB 3.67%
- ACAD N/A
- EPS Growth
- ASB N/A
- ACAD N/A
- EPS
- ASB 1.20
- ACAD 0.78
- Revenue
- ASB $1,007,710,000.00
- ACAD $929,236,000.00
- Revenue This Year
- ASB N/A
- ACAD $37.34
- Revenue Next Year
- ASB $17.50
- ACAD $7.25
- P/E Ratio
- ASB $20.87
- ACAD $22.41
- Revenue Growth
- ASB N/A
- ACAD 47.06
- 52 Week Low
- ASB $19.40
- ACAD $14.15
- 52 Week High
- ASB $28.18
- ACAD $32.59
- Technical
- Relative Strength Index (RSI)
- ASB 42.75
- ACAD 54.79
- Support Level
- ASB $24.90
- ACAD $16.78
- Resistance Level
- ASB $26.62
- ACAD $17.60
- Average True Range (ATR)
- ASB 0.55
- ACAD 0.68
- MACD
- ASB -0.24
- ACAD -0.03
- Stochastic Oscillator
- ASB 13.04
- ACAD 45.21
About ASB Associated Banc-Corp
Associated Banc-Corp is a bank holding company. The company through its subsidiaries provides a broad array of banking and nonbanking products and services to individuals and businesses. The company operates in three reportable segments; Corporate and Commercial Specialty; Community, Consumer, and Business; and Risk Management and Shared Services. The majority of its revenue is derived from the Corporate and Commercial Specialty and Community, Consumer, and Business segments.
About ACAD ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.